US 9982265
Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation and lung injury
granted A61KA61K31/275A61K31/497
Quick answer
US patent 9982265 (Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation and lung injury) held by The Board of Regents of the University of Texas System expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/275, A61K31/497, A61K31/506, A61K31/519